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Introduction: Gastric varices are frequently seen in patients with portal hypertension. The mainstay of treatment 
is variceal injection with a mixture of N-butyl-2-Cyanoacrylate and lipiodol. The use of N-butyl-2-Cyanoacrylate 
without lipiodol is not extensively studied and it can be a cost-effective approach. The objective of our study was 
to evaluate whether the use of N-butyl-2-Cyanoacrylate without lipiodol is a safe and effective endoscopic 
treatment for gastric varices.  
Material and Methods: This prospective observational study was conducted between June 2016 and May 2017 at 
the Department of Gastroenterology, Gujranwala Medical College/ DHQ Teaching Hospital, Gujranwala. A total 
of 100 patients with gastric varices diagnosed on upper GI endoscopy were enrolled in the study. N-butyl-2-
Cyanoacrylate without lipiodol was injected into the gastric varices of all the patients. All procedures were 
performed by experienced gastroenterologists. The patients underwent monthly follow-up endoscopies to 
determine the outcome and adverse events.  
Results: Out of 100 patients, 40 patients (40 %) were men and 60 (60%) were women. The mean age was 53 years. 
The mean volume of N-butyl-2-Cyanoacrylate used per session was 1.5ml ± 0.5 ml (range 1-2ml). Obliteration of 
Gastric varices was achieved in 92 patients (92%) while in 04 patients (4%) varices did not obliterate over a mean 
follow-up of 12 months. No treatment-related immediate or late complications were observed in all patients. Four 
patients (4%) died of delayed rebleeding (after two weeks of intervention).  
Conclusion: Injection therapy of gastric varices with N-butyl-2-Cyanoacrylate alone without lipiodol is a safe and 
cost-effective method for gastric varices.  
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Liver cirrhosis is a global health problem. In patients 
with liver cirrhosis, the rate of varices formation is 5 to 
15% per year, and 25% of patients with varices will 
develop variceal hemorrhage.1 Despite the recent 
advancement in the management, variceal hemorrhage 
has a 6-week mortality rate of 10%-20%.2,3 Though 
when compared with esophageal varices, the gastric 
varices bleed less frequently but they bleed with 
greater intensity.4 The gold standard test to diagnose 
and classify these varices is upper GI endoscopy. Sarin 
et al classified esophageal varices according to their 
size and the gastric varices according to their location 
& concomitant presence of esophageal varices.4 
Different methods have been used for the management 
of gastric varices which include band ligation, sclerosis 
with ethanolamine oleate, and obturation with tissue 
glues like N-Butyl 2-cyanoacrylate and TIPS 
(transjugular intrahepatic portosystemic shunts). There 
is also a case report of using hemostatic nanopowder 
for bleeding gastric varices.5 A study comparing 
conventional sclerotherapy with cyanoacrylate glue 
injection showed that cyanoacrylate glue injection is 
more effective than conventional sclerosis for 
controlling first variceal hemorrhage.6 Other studies 
comparing the tissue glues with band ligation have 
also concluded that bleeding control was similar in 
both groups but rebleeding was more in-band ligation 
in long-term follow-up.7,8 TIPS (transjugular 
intrahepatic portosystemic shunts) is an effective 
alternative to endoscopic intervention in patients with 
Child-Pugh class C (due to the high risk of treatment 
failure).9 In 1986, Nib Sohendra et al, successfully 
obliterated gastroesophageal varices using N-butyl-2-
Cyanoacrylate, which is now being practiced in 
different countries of Europe and Asia. 10 
Cyanoacrylate injection has also been shown to 
prevent the first episode of bleed in patients with 
gastric varices when compared with beta-blockers.11 
Most common side effects seen with Cyanoacrylate 
injection therapy are re-bleeding due to glue cast 
extrusion, sepsis, distant embolism, and gastric ulcer 
formation.12 
Technical Consideration: 
N-butyl-2 cyanoacrylate is a chemical substance that 
solidifies on contact with an aqueous medium, 
through a polymerization process. Lipiodol is a poppy 
seed oil that when mixed with N-butyl-2 cyanoacrylate 
delays the polymerization process by 20 seconds thus 
preventing the blockage of the injection needle. 
However, the use of lipiodol increases the overall cost 
of the procedure to about more than 10 times, a serious 
concern in developing countries. When used with care 
and expertise, N-butyl-2 cyanoacrylate can be injected 
without mixing with it lipiodol, thus making it a cost-
effective approach. 
 
Materials and Methods 
 
This prospective observational study was conducted at 
the Department of Gastroenterology, Gujranwala 
Medical College/DHQ Teaching Hospital, Gujranwala 
from June 2016 to May 2017. A total of 100 patients 
with gastric varices diagnosed on upper GI endoscopy, 
were enrolled in the study. A sample size of 100 was 
calculated using a 95% confidence interval, a 5% 
margin of error, and taking an expected outcome of 
93%. Informed written consent was taken from all 
study participants after the approval from the ethical 
board. Their demographic data, history, and clinical 
examinations were recorded. 
Instruments & Technique: 
All the patients received standard medical treatment 
of upper GI bleeding. Gastroscopy was performed to 
define the type of gastric varices according to Sarin 
classification. A standard sclerotherapy injection 
needle of 21G was used in all patients. Distilled water 
was instilled into the catheter to fill the dead space 
within it. Cyanoacrylate was filled in a 5cc syringe. 
After puncturing gastric varix, N-butyl-2 
cyanoacrylate (1 to 2ml mL) was rapidly injected into 
varix by an expert endoscopy technician, followed by a 
rapid push of distilled water (quantity pre-calculated 
according to the dead space). Monthly follow-up 
endoscopy was performed in all the patients to assess 
the treatment success i.e varix obliteration and further 




100 patients received injection treatment with N-butyl-
2 cyanoacrylate glue for the gastric varices. The mean 
age was 53 years (range 28-60 years), 40 patients (40 
%) were men and 60 (60%) were women. All the 
patients had liver cirrhosis (Child A cirrhosis in 40 
patients, Child B cirrhosis in 50, and Child C cirrhosis 
in 10 patients). Concomitant esophageal varices were 
present in 62 patients (GOV2) and 38 patients had 
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Table 1: Characteristics of Patients 
 Number Percentage 
(%) 






Mean Age (Range) year 53 (28-60)  
Child Class (A/B/C) 40/50/10  


















Table 2: Results of Cyanoacrylate Glue Treatment 
 Value Percentage 
% 
Mean Cyanoacrylate 
per session (Range) 
1.5 ml (1-2ml)  
No. of Sessions per 
patient 1/2/3/4 
6/36/40/10  
Rebleeding   
Treatment Success 92 92% 
Treatment Failure 04 4% 
Deaths  04 4% 
 
The mean volume of N-butyl-2-Cyanoacrylate used 
per session was 1.5ml ± 0.5 ml (range 1-2ml). Initial 
hemostasis was achieved in all 10 patients who 
presented with active variceal bleeding. The mean 
follow-up time was 12 months. Complete obliteration 
of gastric varices was achieved in 92 patients (92%). 
This required a single session in 06, two sessions in 36, 
and three sessions in 40 patients, and four sessions in 
10 patients. Two patients (2%) had early re-bleeding 
(within 24 hours) and five patients (05%) had late 
rebleeding (after 24 hours) that were successfully 
managed with another session of glue injection.  
Treatment failure (failure to obliterate gastric varix 
after four sessions) was noted in four patients (04%). 
Four patients (4%) died due to delayed bleeding (after 
2 weeks of therapy). 
 




The most common cause of upper GI bleed is Peptic 
ulcer disease13 but in patients with cirrhosis, variceal 
hemorrhage is the major cause.14 The prevalence of 
esophageal varices in compensated cirrhosis is about 
30% and in decompensated cirrhosis is about 60%.15 
Treatment options for patients with bleeding from 
gastric varices are octreotide, terlipressin, and TIPS. 
Endoscopic therapy with cyanoacrylate glue is another 
viable option not only in cases where TIPS is not 
feasible or available but also as a sole therapy. The 
glue typically is combined with lipiodol solution. Our 
study showed that endoscopic injection of gastric 
varices with cyanoacrylate without using lipiodol is a 
cost-effective approach in all patients whether they 
present with active bleeding or the treatment is given 
for prophylaxis. A randomized controlled trial, 
comparing the effectiveness of cyanoacrylate glue 
injection, b-blockers, and no treatment also showed 
that primary hemorrhagic from gastric varices was less 
frequent in those treated with cyanoacrylate glue 
injection compared with those who were treated with 
beta-blockers or no treatment.16 Mixing of lipiodol 
with cyanoacrylate delay the polymerization process 
but it tremendously increases the overall cost of the 
procedure. So, when used with care and expertise, the 
cyanoacrylate glue can be injected successfully into 
varix without using lipiodol. A similar study was 
published in 2014 in which undiluted cyanoacrylate 
and methacryloxysulfolane (NBCM) was used to 
obturate the gastric varices in twenty patients without 
mixing it with lipiodol and eradication of gastric 
varices was noted in all patients over a median follow-
up of 31 months. 13 patients required only one session 
& the rest seven required two sessions. The maximum 
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volume of NBCM injected was 2ml. No complications 
were observed in all patients except mild epigastric 




Injection therapy of gastric varices with N-butyl-2-
Cyanoacrylate alone without the use of lipiodol is a 
safe and cost-effective method in the endoscopic 
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